ORIC PHARMACEUTICALS INC (ORIC)

US68622P1093 - Common Stock

9.61  +0.24 (+2.56%)

After market: 9.4108 -0.2 (-2.07%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
110.78M91.77M78.87M49.35M28.57M
Research and Development
85.17M66.68M56.86M35.92M22.84M
Selling, General, and Administrative Expenses
25.61M25.09M22.01M13.42M5.73M
Operating Income
-110.78M-91.77M-78.87M-49.35M-28.57M
Interest Income/Expense
10.08M2.65M140.00K310.00K1.40M
Other Income/Expense
N/A0.0020.00K180.00K290.00K
Non Recurring Items
N/AN/A0.00-24.84MN/A
Income Before Taxes
-100.70M-89.12M-78.72M-73.70M-26.88M
Net Income
-100.70M-89.12M-78.72M-73.70M-26.88M
EBITDA
-109.75M-90.80M-77.97M-48.38M-27.54M
 
Per Share Data
EPS Diluted Total Ops
-1.96-2.25-2.07-3.36-0.98
Non GAAP EPS
-1.96-2.25-2.07-6.22N/A
 
Statistics

All data in USD

Charts